|
Model Number 1322.09.500 |
Device Problem
Naturally Worn (2988)
|
Patient Problems
Unspecified Infection (1930); Toxicity (2333); No Code Available (3191)
|
Event Date 05/23/2018 |
Event Type
Injury
|
Manufacturer Narrative
|
No anomalies detected by checking the sterilization charts of all the lot# involved (smr stem lot# 201003699; smr humeral head ø50 mm, lot#200908346; adaptor taper, lot# 201003330; smr hum.Body, lot# 201001559; smr glenoid, lot# 201001341) on the overall number of pieces manufactured with these lot#, thus indicating that the products were correctly sterilized before being placed on the market.No other complaints received on these components.We will send a final emdr once the evaluation will be concluded.
|
|
Event Description
|
Shoulder revision surgery due to infection performed on (b)(6) 2018.According to the info reported: primary surgery due to trauma was performed on (b)(6) 2010.Smr anatomic was implanted during this surgery; revision surgery initially performed in an unknown date due to unknown issue.During this first revision surgery, surgeon removed only the l2 liner previously implanted causing the cocr head to articulate on the mb baseplate.Wear of components and metallosis were experienced; removal of all the components previously implanted during the revision surgery performed on (b)(6) 2018.Event happened in (b)(6).
|
|
Event Description
|
First stage of shoulder revision surgery due to infection performed on (b)(6)2018.According to the info reported: - primary surgery due to trauma was performed on (b)(6)201.Smr anatomic total was implanted during this surgery; - first revision surgery performed in an unknown date due to unknown issue.During this revision surgery, surgeon removed only the l2 liner previously implanted causing the cocr humeral head to articulate on the mb glenoid baseplate.Wear of components and metallosis were experienced; - removal of all the components previously implanted during the first stage revision surgery due to infection performed on (b)(6)2018.No info about a second stage revision performed and/or components eventually implanted.According to the info reported by complaint source, surgeon responsible for removing only the l2 liner previously implanted was not specialized in shoulder arthroplasty.Moreover, according to ahpra (australian health practitioner regulation agency), he was not legally able to practise.Event happened in australia.
|
|
Manufacturer Narrative
|
Unfortunately, very few info received about this case.Explants analysis: explants not available to be returned to limacorporate.According to the info reported, explants were disposed of as per hospital policy.X-rays analysis: no x-rays available.Check of dhr: no anomalies detected by checking the sterilization charts of all the lot# involved (smr stem lot# 201003699; smr humeral head ø50 mm, lot#200908346; adaptor taper, lot# 201003330; smr hum.Body, lot# 201001559; smr glenoid, lot# 201001341) on the overall number of pieces manufactured with these lot#, thus indicating that the products were correctly sterilized before being placed on the market.No other complaints received on these components.According to the info reported, surgeon responsible for the first stage revision due to infection performed on (b)(6)2018 was "shocked" and rather confused as to why the previous surgeon did not perform a conversion to a reverse shoulder implant.At this stage, by considering the very few info provided and based on the analysis we could perform, we can conclude that infection is not product-related.Wear of components and metallosis was experienced due to negligence of the previous surgeon (not legally able to practice) responsible for removing only the poly liner implanted on 23rd of august, causing a direct contact between the humeral head and the metal back glanoid baseplate.Pms data: we are aware of two cases (including this one) of experienced wear and metallosis of a cocr humeral head (used in smr anatomic total) belonging to the family 1322.09.Xxx on a total of (b)(4) cocr humeral heads sold ww since 2002.Specific revision rate of (b)(4).No corrective action for this specific case.Limacorporate will continue monitoring the market.
|
|
Search Alerts/Recalls
|
|
|